Fasting & GLP-1 Meds: A Risky Combination?

Millions worldwide are now using GLP-1 medications, including Ozempic and Mounjaro, for diabetes or weight loss. These drugs significantly impact religious observances involving fasting, such as the upcoming Yom Kippur fast on September 20-21, 2026. While most patients can fast safely, expert guidance is crucial, especially for those with diabetes.

GLP-1 drugs mimic a natural hormone, slowing digestion and reducing appetite. However, common side effects like nausea and dehydration can be worsened by fasting. It's advised to avoid starting new medications or increasing doses two weeks before a fast. For weekly injections, maintaining the schedule is usually recommended.

Daily oral GLP-1 medications require careful timing, potentially necessitating breaking the fast. Skipping doses can be dangerous for diabetic patients, risking high blood sugar or severe side effects if doubled later. Pancreatitis is a rare but serious risk for all users, especially when combined with fasting.

Diabetic patients, particularly those using insulin or sulfonylureas alongside GLP-1s, face the greatest risk of dangerously low blood sugar. Consultation with a doctor is vital to adjust medication schedules and doses. Individuals with Type 1 or poorly controlled diabetes are strongly advised against fasting.

Preparation is key for anyone fasting on GLP-1s. This includes consulting a doctor, eating a balanced pre-fast meal, and staying hydrated. During the fast, regular blood sugar monitoring is essential for diabetics. Promptly breaking the fast at the first signs of distress or abnormal blood sugar levels is paramount, with a balanced meal recommended afterward.